The small cap share gained up to 4.85% to Rs 187.90 against previous close of Rs 179.20 on BSE

A slowing economy and widespread stress in India Inc. are creating opportunities for promoters and strategic investors to ink M&As, buy back shares and delist

Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals

The pharma share gained up to 4.44% to Rs 753.4 against previous close of Rs 721.50 on BSE

Coronavirus vaccine news update: Only 100 participants out of the 375 volunteers would be picked for the first and second phases. The rest would participate in trials at other sites

\"We are looking at about seven or a little more than seven months for the vaccine, provided the data is encouraging and the vaccine is proven to be effective during the trials,\" Chairman Pankaj Patel told Reuters in an interview

Coronavirus vaccine news: Lakshmi Mittal said that the importance of dedicated and ongoing research in this field cannot be overestimated

Last month, Cipla introduced Remdesivir under the brand name 'CIPREMI' after receiving approval from DCGI for \"restricted emergency use\" on adult and paediatric patients hospitalised with suspected or laboratory-confirmed COVID-19 infection

Stock Market LIVE Updates on July 13: RIL, Infosys, Tech Mahindra, Tata Steel, IndusInd Bank, HUL and Maruti were among the other gainers on Sensex pack today. On the other hand, Bharti Airtel and HDFC were among the top laggards

Businesses are increasingly adopting safer and smarter ways of manufacturing and delivering services

They will give the green signal. Then the medicine people will examine and the first shot of the vaccine will be given due observation,\" NIMS director Dr K Manohar told

A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support

These complex tests were priced at Rs 2 to Rs 2.5 lakh in India until a few years ago. The results took long as the labs procured them from abroad. Now most of these tests can be done in India at costs starting at Rs 3,000

Coronil: Patanjali stated that they have shared all the clinical trial data with the AYUSH ministry and that the ministry has categorically agreed that Patanjali Research Foundation has appropriately worked on coronavirus management

TikTok removed from Android, Apple play stores after govt ban on 59 Chinese appsA day after the Indian government ordered a ban on 59 Chinese mobile apps over security reasons amid the India-China border tension, the popular video app TikTok has been removed from Android's Play Store and Apple store. The popular Chinese app has over 120 million active users, mostly those in the 20s, in India alone. Mukesh Ambani's RIL set to acquire Kishore Biyani-led Future GroupMukesh Amban...

Announcing the same at a virtual media briefing, Delhi Chief Minister Arvind Kejriwal stated that the plasma bank will start operating in the national capital in the next two working days

While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough

The coronavirus might linger on for many years, but effective e-commerce and hybrid fulfilment methods will help propel the retail industry forward and help retailers weather such storms now and in the future

Coronavirus testing facilities in India: Check out cost of tests, COVID-19 testing centres near you as listed by ICMR

Patanjali claims that 69 percent of the patients showed recovery on Day 3 PCR tests and 100 percent recovery on test conducted on the 7th day, which was 35 percent better recovery than the patient group on placebo